McIlrath & Eck’s AdaptHealth AHCO Stock Holding History

McIlrath & Eck’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-100	Closed	-$2K	–	834
2022 Q2	$2K	Buy	+100	New	+$1.62K	﹤0.01%	718

Other funds holding AHCO

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

McIlrath & Eck's AHCO Position: Q3 2022 in Review

McIlrath & Eck sold out of AdaptHealth (AHCO) in Q3 2022, closing a stake of 100 shares — an estimated $2K sold.

McIlrath & Eck first reported a position in AHCO in Q2 2022 and held it in 1 quarter. The position peaked at $2K in Q2 2022. 184 funds tracked by Wall St. Rank hold AHCO as of Q3 2022.

McIlrath & Eck reported no remaining AdaptHealth position as of Q3 2022 after selling out during the quarter.
McIlrath & Eck sold 100 AdaptHealth shares in Q3 2022, an estimated $2K.
McIlrath & Eck first reported a position in AdaptHealth in Q2 2022 and held it in 1 quarter.
McIlrath & Eck's AdaptHealth position peaked at $2K in Q2 2022.
184 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2022.

Based on McIlrath & Eck's 13F filing for Q3 2022, filed 18 Oct 2022.